Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

UCLA Unveils Key Clinical Trial Outcomes and Imaging Breakthroughs in Radiation Oncology at ASTRO 2025

Newsdesk profile image
by Newsdesk
UCLA Unveils Key Clinical Trial Outcomes and Imaging Breakthroughs in Radiation Oncology at ASTRO 2025

AI-Generated Summary

Physicians and scientists from UCLA Health Jonsson Comprehensive Cancer Center are presenting significant clinical trial results and research advances in radiation oncology at the 2025 ASTRO Annual Meeting. Highlights include findings on targeted radioactive therapy for recurrent prostate cancer, stereotactic body radiation therapy (SBRT) for prostate and head and neck cancers, and novel imaging techniques like 5DCT and MRI-guided SBRT. These studies underscore innovative approaches aimed at enhancing the safety, precision, and effectiveness of cancer treatment.

In a nutshell

This article offers critical insights into the evolving landscape of radiation oncology, showcasing promising advancements in both therapeutic strategies and diagnostic imaging. These findings are highly relevant for healthcare professionals seeking to understand the next generation of cancer treatment and precision medicine.

Source: News-Medical.net

Newsdesk profile image
by Newsdesk

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More